{"SPADE_N_05543": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_05543", "Peptide Name": "Enterocin 7A(Bacteriocin)", "Source": "Enterococcus faecalis MRR 10-3; Enterococcus faecalis 710C", "Family": "Belongs to the class IId bacteriocin", "Gene": "mr10A", "Sequence": "MGAIAKLVAKFGWPIVKKYYKQIMQFIGEGWAINKIIDWIKKHI", "Sequence Length": 44, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q1A2D3"], "Protein Existence": "", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "Gram-positive (broad-spectrum)", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Cell membrane", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Both peptides are primarily alpha-helical, adopting a similar overall fold. The structures can be divided into three separate alpha-helical regions: the N- and C-termini are both alpha-helical, separated by a central kinked alpha-helix. The overall structures bear an unexpected resemblance to carnocyclin A, a 60-residue peptide that is cyclized via an amide bond between the C- and N-termini and has a saposin fold.", "Formula": "C251H390N60O54S2", "Mass": 5176.28, "PI": 10.0, "Net Charge": 7, "Hydrophobicity": 0.2, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Comments": "leaderless, i.e. no signal peptide. The amino acid sequence of enterocin 7A is identical to that of MR10A. However, enterocin 7A is N-terminally formylated. Remarkably, the peptide is helical in aqueous solution.Enterocins 7A and 7B each display strong activity by themselves without their partner.", "Literature": [{"Title": "Characterization of antimicrobial substances produced by Enterococcus faecalis MRR 10-3, isolated from the uropygial gland of the hoopoe (Upupa epops).", "Pubmed ID": "16751538", "Reference": "Appl Environ Microbiol. 2006 Jun;72(6)4245-9.", "Author": "Mart", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16751538"}, {"Title": "Solution structures of the linear leaderless bacteriocins enterocin 7A and 7B resemble carnocyclin A, a circular antimicrobial peptide.", "Pubmed ID": "23725536", "Reference": "Biochemistry. 2013 Jun 11;52(23)3987-94.", "Author": "", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23725536"}], "Frequent Amino Acids": "IKA", "Absent Amino Acids": "CORSTU", "Basic Residues": 9, "Acidic Residues": 2, "Hydrophobic Residues": 26, "Polar Residues": 20, "Positive Residues": 9, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00143", "Similarity": 0.9772727272727273, "Sequence": "MGAIAKLVAKFGWPIVKKYYKQIMQFIGEGWAINKIIEWIKKHI"}, {"SPADE_ID": "SPADE_N_00155", "Similarity": 0.7857142857142857, "Sequence": "APAGLVAKFGRPIVKKYYKQIMQFIGEGSAINKIIPWIARMWRT"}, {"SPADE_ID": "SPADE_N_05542", "Similarity": 0.7441860465116279, "Sequence": "MGAIAKLVAKFGWPFIKKFYKQIMQFIGQGWTIDQIEKWLKRH"}]}}}